Patients carrying strong cytoplasmic NANOG-expressing lesions (score 2) experienced a significantly higher progression to laryngeal cancer than those with absent to moderate (scores 0–1) expression (HR = 1.826; 95%CI, 1.222–2.728; P = 0.003). Here, NANOG is linked to laryngeal carcinoma.